Membrane Chromatography Market Size

Membrane Chromatography Market Analysis

The Membrane Chromatography Market size is estimated at USD 315.61 million in 2024, and is expected to reach USD 662.89 million by 2029, growing at a CAGR of 16% during the forecast period (2024-2029).

The COVID-19 pandemic affected the market. Due to lockdowns and supply chain issues related to the chromatographs, the market was adversely affected during the initial phase. However, initiatives by key market players are expected to increase market growth. For instance, in December 2022, Shimadzu entered into a collaboration with the University Medical Center Göttingen, Germany. The collaboration will focus on the development of new clinical laboratory methods using liquid chromatography-mass spectrometry for therapeutic drug monitoring (TDM) analysis. Thus, such collaborations are expected to increase market growth.

Membrane chromatography is a well-established technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors and in polishing steps for the removal of DNA, host cell protein impurities (HCP), and viruses. The increasing demand for biopharmaceuticals and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors for the growth of this market. There has been an increase in the acceptance of biopharmaceuticals in recent times. Several key market players have been obtaining approvals from regulatory organizations for biopharmaceutical manufacturing and supply for various disease treatments. For instance, in October 2022, 3P Biopharmaceuticals received approval from the United States Food and Drug Administration (USFDA) that the 3P facilities were acceptable for the manufacture of the target molecule and appropriate for commercialization in the United States once the product is authorized by USFDA. Moreover, the increase in R&D spending in the biopharmaceutical sector aided in the growth of the market. For example, according to 'The Pharmaceutical Industry and Global Health Facts and Figures 2021' published by the International Federation of Pharmaceutical Manufacturers & Associations, the annual research and development spending of the biopharmaceutical industry has been 7.3 times greater than that of the aerospace and defense, industries, 6.5 times more than that the chemicals industry, and 1.5 times more than that of the software and computer services industry. As per the report, in 2022, over 202 billion was estimated to be spent around the world in biopharmaceutical research and development. The large investments in the market are considered a result of the rising acceptance of biopharmaceuticals over the years.

However, the limited use of membrane chromatography in large-scale manufacturing is expected to restrain the growth of this market during the forecast period.